​

Funding Round

Series E - Selecta Biosciences

Series E - Selecta Biosciences

Investment Firm

Overview

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

Announced Date

Sep 08, 2015

Closed on Date

Sep 08, 2015

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

12

Investor Name
Participant Investor+ND Capital
Participant InvestorI2BF Global Ventures
Participant InvestorOUP (Osage University Partners)
Participant InvestorPolaris Partners
Participant InvestorFlagship Pioneering

Round Details and Background

Selecta Biosciences raised $38000000 on 2015-09-08 in Series E

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

Company Funding History

20

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 27, 2011
Series D - Selecta Biosciences
1-47.3M
Aug 17, 2010
Grant - Selecta Biosciences
1-3.0M
Apr 05, 2010
Series C - Selecta Biosciences
5-15.0M
Feb 25, 2009
Series B - Selecta Biosciences
4-15.1M

Recent Activity

There is no recent news or activity for this profile.